Naiyila Xiaokaiti

Dr. Naiyila Xiaokaiti

West China Hospital of Sichuan University, Chengdu, Sichuan, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NXNaiyila Xiaokaiti
Naiyila Xiaokaiti
JLJinze Li
Jinze Li
YHYin Huang
Yin Huang
BCBo Chen
Bo Chen
MZMengli Zhu
Mengli Zhu
DCDehong Cao
Dehong Cao
Benign prostatic hyperplasia (BPH) is a common male condition that impacts many men’s quality of life by generating lower urinary tract symptoms (LUTS). In recent years, inflammation has become very common in the prostate, and BPH with inflammation has a higher International Prostate Symptom Score (IPSS) score and an enlarged prostate. Chronic inflammation leads to tissue damage and the release of pro-inflammatory cytokines, which play an important role in the pathogenesis of BPH. We will focus on current advancements in pro-inflammatory cytokines in BPH, as well as the future of pro-inflammatory cytokine research.